These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 6419355
1. [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin]. López Fernández MF, Batlle Fonrodona FJ, Ginsberg MH, Ruggeri ZM, Zimmerman TS. Sangre (Barc); 1983; 28(4):439-49. PubMed ID: 6419355 [No Abstract] [Full Text] [Related]
2. Time course of changes in in vitro platelet function and plasma von willebrand factor activity (VIIIR:WF) and factor VIII-related antigen (VIIIR:Ag) in the diabetic rat. Winocour PD, Lopes-Virella M, Laimins M, Colwell JA. J Lab Clin Med; 1983 Nov; 102(5):795-804. PubMed ID: 6415193 [Abstract] [Full Text] [Related]
9. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation]. Tran TH, Lämmle B, Marbet UA, Ritz R, Marbet GA, Duckert F. Schweiz Med Wochenschr; 1981 Oct 10; 111(41):1542-3. PubMed ID: 6797063 [Abstract] [Full Text] [Related]
10. von Willebrand factor can substitute for plasma fibrinogen in ADP-induced platelet aggregation. Timmons S, Hawiger J. Trans Assoc Am Physicians; 1986 Oct 10; 99():226-35. PubMed ID: 3496699 [No Abstract] [Full Text] [Related]
11. [Factor VIII/von Willebrand factor complex (FVIII/vWF)]. Yoshioka A. Rinsho Byori; 1985 Feb 10; Spec No 61():73-85. PubMed ID: 3923232 [No Abstract] [Full Text] [Related]
13. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases]. Shinmyozu K, Maruyama Y, Ohkatsu Y, Maruyama I, Igata A. Rinsho Shinkeigaku; 1983 Feb 10; 23(2):172-9. PubMed ID: 6407797 [No Abstract] [Full Text] [Related]
14. The in vitro association of antihemophilic factor and von Willebrand factor. Zucker MB, Soberano ME, Johnson AJ, Fulton AJ, Kowalski S, Adler M. Thromb Haemost; 1983 Feb 28; 49(1):37-41. PubMed ID: 6405497 [No Abstract] [Full Text] [Related]
15. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography. Orthner CL. J Lab Clin Med; 1984 Nov 28; 104(5):816-28. PubMed ID: 6436416 [Abstract] [Full Text] [Related]
16. Von Willebrand activity of low molecular weight human Factor VIII increases by binding to gold granules. Furlan M, Perret BA, Beck EA. Thromb Haemost; 1981 Jun 30; 45(3):242-6. PubMed ID: 6792738 [Abstract] [Full Text] [Related]
17. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Ciborowski M, Tomasiak M, Rusak T, Winnicka K, Dobrzycki S. Blood Coagul Fibrinolysis; 2008 Sep 30; 19(6):557-67. PubMed ID: 18685439 [Abstract] [Full Text] [Related]
19. [Platelet aggregation and von Willebrand's factor in 32 insulin-dependent diabetics. Value of the measurement of filtration pressure in the presence of ADP]. Prost-Dvojakovic RJ, Lecrubier C, Lanoe R, Batchvarova V, Samama M. Journ Annu Diabetol Hotel Dieu; 1976 May 30; ():239-47. PubMed ID: 1087675 [No Abstract] [Full Text] [Related]
20. Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/VWF. Cockburn CG, de Beaufre-Apps RJ, Wilson J, Hardisty RM. Thromb Res; 1981 Feb 01; 21(3):295-309. PubMed ID: 6454278 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]